Choroidal Melanoma Clinical Trial
Official title:
10 Years Report of Combined Simultaneous Transpupillary Thermotherapy and ICG-based Photodynamic Therapy for Choroidal Melanoma
This is a report of 10 years results of combined Transpupillary thermotherapy (TTT) treatment with Indocyanine green (ICG) in controlling small and medium-sized choroidal melanomas.
The study was done in a Clinical practice setting. Forty six eyes of 46 patients with small or medium-sized choroidal melanomas were treated with i-TTT using infrared light delivered from a diode laser. All patients were evaluated to rule out systemic metastasis and underwent a complete ophthalmological evaluation including: Slit lamp biomicroscopy, dilated fundus examination, Fluorescein angiography, Optical coherence tomography and A/B ultrasonography. Main outcome measures were: Changes in visual acuity, complications associated with the treatment and local control of the tumor. ;
Observational Model: Case-Only, Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00680225 -
Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma
|
Phase 3 | |
Completed |
NCT00750399 -
Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma
|
Phase 1 | |
Recruiting |
NCT03941379 -
A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma
|
||
Completed |
NCT02875652 -
Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU)
|
N/A | |
Completed |
NCT00765921 -
Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma
|
Phase 1 | |
Completed |
NCT00351728 -
Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone
|
N/A | |
Completed |
NCT01460810 -
Safety and Efficacy of Silicone Oil Tamponade for Surgical Attenuation of Radiation Damage in Choroidal Melanoma
|
N/A | |
Completed |
NCT01251978 -
Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma (Cohort 2)
|
Phase 2 | |
Completed |
NCT00344799 -
Cytogenetic Study of Ocular Melanoma
|
||
Completed |
NCT03052127 -
Study in Subjects With Small Primary Choroidal Melanoma
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT00111046 -
Pain Relief - Tramadol Versus Ibuprofen
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007690 -
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma
|
Phase 3 | |
Active, not recruiting |
NCT04417530 -
Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma
|
Phase 2 | |
Terminated |
NCT05266430 -
Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM)
|